New Radical Reactions by Means of Trialleylmanganate

1. 3-碘代苯1醚， N，N-二胺1 - 2-碘代苯胺对三烷基锰酸的基本循环化（II）对2-碘代苯丙基醚进行治疗，由MnClyD 22-碘代苯D2和三个摩尔剂量的丁基硫醚，在88%的yield中，THF中含有3-异丙基-2，3-二氢苯并呋喃。反应过程就像后续行动一样。单电子从三苯甲基锰酯转移到2-碘酚衍生物将给予一种阴离子激进分子，即在碘代阴离子下产生苯基基的基础。Exo-mode的自由基循环化应该有影响力的第三碳自由基，其中n-BuMn可以给二烷基锰化合物。脱水管理将提供最终产品。用三烷基锰酯的宝石-双溴化合物的反应与三烷基锰酯的化学反应已经实现。这种反应是由Bromine-Manganese Exchange发起的。然后烷基组将从芒果迁移到溴化元素下的附着碳。第二个烷基是由RX可以提供的烷基产品。该反应已成功地应用于从二溴甲基三烷基硅烷开始的烯烃的准备。二烯、埃尼和二烯的三烯基锰介导的循环化;二烯基锰与三烯基锰酯提供的双环化产品含有七个成员环。N，N-Bis （2-nonynyl）苯并胺提供了9-苯并基-2，6-二己基-9-氮杂环的混合物[5]。3. 0]十月-1（7），2-二烯和9-苯并-2，6-二己基-9-氮杂环[5]。3. 0]- 十月-1（7），3-二烯，对三聚氰胺进行治疗。

1. Radical cyclization of ally1 2-iodopheny1 ether, N, N-dially1-2-iodoaniline by means of trialkylmanganate (II)Treatment of 2-iodophenyl prenyl ether with tributylmanganate, generated from MnClィイD22ィエD2 and three molar amounts of butylithium, in THF afforded 3-isopropenyl-2, 3-dihydrobenzofuran in 88% yield. The reaction proceeds as follows. Single electron transfer from tributylmanganate to 2-iodophenol derivative would give an anion radical which generate phenyl radical under departure of the iodide anion. Exo-mode radical cyclization should afford tertiary carbon radical which recombines with n-BuMn to give the dialkylmanganese compound. Dehydromanganation would provide the final product.2. Reaction of gem-dibromo compounds with trialkylmanganateDialkylation of gem-dibromocyclopropanes with trialkylmanganate was achieved. The reaction was initiated by bromine-manganese exchange. Then alkyl group would migrate from manganese to adjacent carbon under bromide elimination. The second alkylation by RX could provide the dialkylation products. The reaction was successfully applied to the preparation of alkenylsilanes starting from dibromomethyltrialkylsilanes.3. Triallylmanganate-mediated cyclization of diyne, enyne, and diene.Treatment of diyne with triallylmanganate provided bicyclized products containing a seven-membered ring. N,N-Bis (2-nonynyl) benzylamine gave a mixture of 9-benzyl-2, 6-dihexyl-9-azabicyclo [5. 3. 0] deca-1 (7), 2-diene, and 9-benzyl-2, 6-dihexyl-9-azabicyclo [5. 3. 0]-deca-1 (7), 3-diene, upon treatment with triallylmanganate.